Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes

Abstract

MS has an incremental impact on SCA in conditions without diabetes. The identification of MS and its individual components is more important for the risk stratification of CVD in non-diabetic individuals.